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use of these techniques for risk stratification of patients 
with severe aortic stenosis or regurgitation and mitral 
regurgitation.
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Abbreviations
AR  Aortic regurgitation
AS  Aortic stenosis
CMR  Cardiovascular magnetic resonance
ECV  Extracellular volume
iECV  Indexed extracellular volume
LGE  Late gadolinium enhancement
MR  Mitral regurgitation
LV  Left ventricle/left ventricular
VHD  Valvular heart disease
Introduction
Valvular heart disease (VHD) is an important public-health 
problem with an increasing prevalence along with ageing 
of the population [1]. Moderate and severe VHD on echo-
cardiography affects 2.5% of the population of the United 
States and increases up to 11.7% in the group of patients 
aged 75 and older [2]. The decision to operate in patients 
with severe VHD is frequently complex and relies on an 
individual risk–benefit analysis. In general, improvement 
in prognosis compared with natural history of the disease 
should outweigh the risk of intervention and its potential 
late consequences, particularly prosthesis-related com-
plications. Current guidelines recommend to intervene in 
Abstract The left ventricular (LV) remodeling process 
associated with significant valvular heart disease (VHD) 
is characterized by an increase of myocardial interstitial 
space with deposition of collagen and loss of myofibers. 
These changes occur before LV systolic function dete-
riorates or the patient develops symptoms. Cardiovascular 
magnetic resonance (CMR) permits assessment of reac-
tive fibrosis, with the use of T1 mapping techniques, and 
replacement fibrosis, with the use of late gadolinium con-
trast enhancement. In addition, functional consequences 
of these structural changes can be evaluated with myocar-
dial tagging and feature tracking CMR, which assess the 
active deformation (strain) of the LV myocardium. Several 
studies have demonstrated that CMR techniques may be 
more sensitive than the conventional measures (LV ejec-
tion fraction or LV dimensions) to detect these structural 
and functional changes in patients with severe left-sided 
VHD and have shown that myocardial fibrosis may not be 
reversible after valve surgery. More important, the pres-
ence of myocardial fibrosis has been associated with lesser 
improvement in clinical symptoms and recovery of LV sys-
tolic function. Whether assessment of myocardial fibrosis 
may better select the patients with severe left-sided VHD 
who may benefit from surgery in terms of LV function and 
clinical symptoms improvement needs to be demonstrated 
in prospective studies. The present review article summa-
rizes the current status of CMR techniques to assess myo-
cardial fibrosis and appraises the current evidence on the 
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patients with symptomatic severe VHD and in asympto-
matic patients with reduced left ventricular (LV) ejection 
fraction, LV dilatation, pulmonary hypertension, right ven-
tricular dilatation and dysfunction and presence of atrial 
fibrillation [1, 3]. However, most of these adverse conse-
quences of severe VHD are observed in advanced stages 
of the disease and are partially irreversible after interven-
tion, leading to suboptimal long-term clinical outcomes [4]. 
Therefore, additional markers that identify early structural 
and functional consequences of severe VHD before irre-
versible damage of the myocardium occurs would help to 
redefine the optimal timing for intervention.
Chronic pressure and volume overload caused by severe 
left-sided VHD results in LV remodeling. Changes in the 
extracellular matrix with deposition of collagen I and loss 
of myofibers at a later stage result in myocardial fibrosis, 
the hallmark of LV remodeling [5, 6]. Cardiovascular mag-
netic resonance (CMR) imaging techniques permit direct 
and indirect assessment of myocardial fibrosis. T1 mapping 
and late gadolinium enhancement (LGE) permit myocardial 
tissue characterization and provide measures of direct myo-
cardial fibrosis whereas CMR tagging and feature track-
ing CMR allow for assessment of myocardial deforma-
tion (strain), a functional parameter that indirectly reflects 
myocardial fibrosis. In addition, advances in molecular 
CMR imaging provide high-specificity tools for detection 
of myocardial fibrosis. This article provides an overview 
of current CMR techniques to assess myocardial fibrosis in 
patients with left-sided VHD.
CMR techniques for direct assessment 
of myocardial fibrosis
LV remodeling in response to chronic pressure and volume 
overload caused by VHD is characterized by progressive 
increase of the interstitial space with increased collagen 
volume fraction (reactive fibrosis) and eventually apopto-
sis of myocardial cells which are replaced by firm fibrous 
tissue (replacement fibrosis or scar). T1 mapping and LGE 
CMR techniques are currently the most frequently used 
techniques to directly assess myocardial fibrosis (Table 1).
CMR T1 mapping
The longitudinal magnetization relaxation time of the 
myocardium, so-called T1 time, is highly sensitive to 
processes that increase the interstitial space and can be 
quantified with various techniques [7]. One of the most 
commonly used in clinical practice is the modified 
Look-Locker pulse sequence where multiple single-shot 
images are acquired intermittently in diastole during 
9–17 cardiac cycles and the inversion recovery curves are Ta
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generated (Fig. 1, panels A and B). The T1 time can be 
obtained for any myocardial segment and T1 maps can be 
generated by determining the T1 time at each pixel loca-
tion (Fig. 1, panel C). Three T1 mapping-derived metrics 
have been proposed as markers of increased myocardial 
fibrosis: the native T1 time, the post-contrast T1 time 
and the myocardial extracellular volume (ECV). With 
the increase of interstitial fibrosis, the native T1 values 
(without the use of gadolinium contrast) become longer 
whereas the post-contrast T1 values become shorter. By 
combining them, myocardial ECV fraction can be com-
puted, which quantifies the extracellular matrix space. In 
the absence of amyloid deposition or edema, collagen I 
is the main component of the extracellular matrix space 
and therefore the myocardial ECV fraction is considered 
a robust marker of myocardial fibrosis [8–10]. The added 
value of these metrics over LGE is the ability to quantify 
the degree of fibrosis and, particularly, to detect diffuse 
interstitial fibrosis, often associated with early stages of 
the disease.
However, it should be noted that the cut-off values of 
the T1 mapping-derived metrics to define fibrosis cannot 
be currently established since the values show considerable 
overlap in normal and diseased myocardium [11]. Moreo-
ver, neither of the techniques is entirely specific to myo-
cardial fibrosis; abnormal myocardial ECV fraction can 
be observed in infiltrative diseases (i.e., amyloidosis) and 
edema, while native T1 values may also be altered in iron 
deposition and diffuse fat infiltration [12]. Furthermore, 
standardization of CMR T1 mapping techniques is neces-
sary to obtain reproducible measurements across different 
vendors and institutions.
Late gadolinium contrast enhanced CMR
LGE CMR is considered the reference standard to quantify 
myocardial replacement fibrosis and scar. The increased 
extracellular space and decreased capillary density of the 
fibrous tissue result in increased volume of distribution 
and prolonged wash-out of gadolinium in comparison to 
Fig. 1  Modified Look-Locker (MOLLI) technique for myocardial 
T1 mapping. After radiofrequency inversion pulse, myocardial tis-
sue longitudinal magnetization in a stable magnetic field returns to 
the equilibrium and a series of images are acquired in diastole over 
several heart beats (A). The images are sorted in order of increasing 
T1 times and the T1 recovery curve is obtained by plotting respec-
tive signal intensities against T1 time (B). The T1 map is obtained by 
applying this technique for all pixels in the image (C). Reproduced 
with permission from Taylor et al. [7]
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the normal myocardium [13]. 10–20 min after intravenous 
administration of gadolinium, inversion recovery images 
are acquired in mid to late diastole. The inversion time is 
chosen to null the normal myocardium and provide the 
best tissue contrast between fibrous tissue, which appears 
bright, and normal myocardium, which appears black. 
Distinct patterns of LGE have been described in various 
cardiac diseases and associated with adverse prognosis 
[14–19] (Fig. 2).
Molecular magnetic resonance imaging
Molecular magnetic resonance imaging with the use of col-
lagen-specific contrast agents is a new experimental method 
for the assessment of myocardial fibrosis. These novel con-
trast agents have shown to improve visualization of scar and 
perfusion defects in animal models of myocardial infarction 
[20, 21]. Furthermore, an elastin/tropoelastin-targeting con-
trast agent has provided interesting insights into the patho-
physiology of remote myocardium extracellular matrix 
remodeling in a mice model of acute myocardial infarction 
[22]. Several other molecular probes have been synthesized 
to study individual processes involved in fibrosis formation, 
like necrosis, apoptosis, inflammation and scar maturation 
[23]. Further efficacy and safety studies are needed before 
clinical implementation. However, the current evidence is 
promising for future improvements in fibrosis detection and 
monitoring of molecular processes associated with myocar-
dial remodeling.
CMR techniques for indirect assessment 
of myocardial fibrosis
The functional consequences of myocardial fibrosis such 
as increased LV stiffness, impaired LV diastolic and sys-
tolic function, can be evaluated with CMR tagging and 
feature tracking CMR (Table  1). These techniques evalu-
ate the active deformation (strain) of the myocardium in 
three orthogonal directions: radial, circumferential and 
Fig. 2  Patterns of late gadolinium enhancement (LGE). A shows no 
LGE, no focal replacement fibrosis. B–E demonstrate different pat-
terns of non-infarct myocardial fibrosis: B diffuse patchy LGE of the 
anterior and lateral wall (arrows); C focal nodular LGE of the infe-
rior wall (arrow); D focal LGE of the anterior and inferior right ven-
tricular insertion points (arrows) and E linear midwall septal LGE 
with additional foci at the right ventricular insertion points (arrows). 
In F, typical infarct-type subendocardial LGE distribution is shown 
(arrows)
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longitudinal. In patients with VHD, the measurement of LV 
ejection fraction, which merely reflects the change in LV 
volumes between systole and diastole, may be misleading. 
For example, in patients with mitral regurgitation, LV ejec-
tion fraction may be preserved for long time since the LV 
is emptying in a low-pressure chamber (left atrium) while 
myocardial longitudinal strain may be impaired [24]. In 
patients with severe aortic stenosis, the LV hypertrophy, 
developed in response to the pressure overload, reduces the 
wall stress and maintains the LV ejection fraction. How-
ever, myocardial longitudinal strain may be impaired [25]. 
CMR tagging and feature tracking CMR track distinctive 
features of the myocardium throughout the cardiac cycle 
and calculate mechanical indices, such as strain, strain-rate, 
twist and torsion.
CMR tagging
This method is based on alteration of the myocardial tis-
sue magnetization to create trackable markers within the 
myocardium which are visualized as dark lines in the form 
of a grid pattern. This allows immediate visual assess-
ment of myocardial deformation, but for a more objective 
approach and quantification additional post-processing is 
employed. Recent developments in pulse sequences and 
image processing have resulted in a plethora of new tag-
ging techniques [26]. The main advantage of CMR tagging 
over feature tracking CMR is that the imposed tags are 
more clearly defined and easier tracked than the natural fea-
tures and are not subjected to through plane displacements, 
thereby providing more reproducible measurements [27]. 
The main shortcomings of this technique are the need for 
additional, elaborate scan sequences with limited accuracy 
when applied to thin myocardium (such as the remodeled, 
thinned-wall LV, the right ventricle and the atria) and the 
time-consuming post-processing.
Feature tracking CMR
Feature tracking CMR is based on post-processing of 
standard steady state free precession cine images, similar 
to echocardiographic speckle tracking. Feature tracking 
CMR algorithms focus on the endo- and epicardial borders 
and detect the in- and outward motion of the cavity-tissue 
interface [27, 28]. Global and segmental LV longitudinal, 
circumferential and radial strain, strain-rates, and LV rota-
tional mechanics can be derived from standard long- and 
short-axis views (Fig.  3). Global rather than segmental 
Fig. 3  Feature tracking cardiovascular magnetic resonance (CMR) in 
a patient with severe aortic stenosis. A Long-axis (top) and a mid-
cavity short-axis (bottom) end-diastolic steady state free precession 
images. Left ventricular endo- and epicardium are contoured (red 
and green lines) and the anterior right ventricular insertion point is 
marked in short-axis (blue dot). B Fully automated feature tracking 
analysis is performed by tracking distinctive features along the out-
lined myocardium borders. C The derived time-strain curves show 
a wide variation in segmental longitudinal strain (top) and normal 
global peak circumferential strain (bottom). The purple colored curve 
corresponds to the anteroseptal segment. D The 16-segment bullseye 
plots for longitudinal (top) and circumferential (bottom) left ventric-
ular strain, showing impaired myocardial deformation of the basal 
interventricular septum. (Feature tracking analysis was performed 
with  cvi42 v5.3, Circle Cardiovascular Imaging, Calgary, Canada)
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strain values appear the most reproducible [29–31]. Addi-
tional methodology standardization is an important prereq-
uisite for wider dissemination of this technique in clinical 
practice.
CMR left ventricular myocardial fibrosis 
assessment in VHD: clinical evidence
Accumulating evidence on the deleterious impact of LV 
myocardial fibrosis on clinical outcomes after surgical 
treatment of left-sided VHD has raised interest on tissue 
characterization and LV strain with CMR techniques [19, 
32–36]. This evidence is summarized for aortic stenosis 
(AS) and regurgitation (AR) and for mitral regurgitation 
(MR) in the following sections.
Aortic stenosis
The pressure overload caused by AS increases LV wall 
stress and as a consequence the myocardium responds 
with myocyte hypertrophy to maintain LV systolic func-
tion. This myocardial hypertrophy is characterized by an 
increased muscle fiber diameter with parallel addition of 
new myofibrils [37]. Furthermore, there is an increase of 
interstitial fibrosis and myocyte apoptosis, partially as a 
consequence of oxygen supply–demand mismatch and 
myocardial ischemia [37–39]. At a late stage in the natural 
history of severe AS, the LV myocardium is characterized 
by large areas of myocyte loss and replacement fibrosis 
causing LV systolic dysfunction and associated with poor 
prognosis [38].
The early changes in the interstitial space with increased 
deposition of collagen I can be assessed with CMR T1 
mapping (Table  2) [8, 34, 40–46]. Several studies have 
validated LV native T1 values and myocardial ECV frac-
tion against histology in patients with AS undergoing aor-
tic valve replacement [8, 34, 40, 41]. In 109 patients with 
moderate and severe AS, Bull and colleagues showed 
that LV native T1 values were significantly higher among 
patients with symptomatic severe AS compared with mod-
erate and asymptomatic severe AS (1014 ± 38 vs. 955 ± 30 
and 972 ± 33  ms, respectively; p < 0.05) (Fig.  4) [40]. A 
significant correlation was observed between native T1 
values and collagen volume fraction assessed on myocar-
dial biopsies (R = 0.65, p = 0.002). Similarly, Flett and 
coworkers validated the measurement of myocardial ECV 
fraction in 18 patients with severe AS [8]. ECV strongly 
correlated with the histological collagen volume fraction 
 (R2 = 0.86; p < 0.001). Although still not implemented in 
routine clinical practice, the measurement of myocardial 
ECV in patients with AS has important clinical implica-
tions [34, 43–46]. Increased ECV has been associated with 
symptoms, worse LV systolic and diastolic function, higher 
levels of cardiac troponin T and ECG strain [34, 43–46]. 
Recently, Chin et  al. reported the prognostic implications 
of myocardial ECV fraction corrected for LV end-dias-
tolic myocardial volume normalized to the body surface 
area (iECV) in 166 patients with mild to severe AS [34]. 
Patients with increased myocardial iECV (≥22.5  ml/m2) 
but without LGE (replacement fibrosis) showed signifi-
cantly higher all-cause mortality and AS-related mortality 
rates (36 per 1000 patients-year for both) as compared to 
the patients with normal myocardium (iECV < 22.5 ml/m2, 
8 and 0 deaths/1000 patient-years) (Fig. 5).
LGE, myocardial replacement fibrosis, is detected in 
19–62% of patients with severe AS [19, 32, 47, 48]. Two 
forms of LGE can be observed: the ischemic and the non-
ischemic pattern. The ischemic pattern is characterized by 
subendocardial LGE along specific coronary artery terri-
tories whereas in the non-ischemic pattern the distribution 
of LGE can be diffuse, (multi)focal or linear, confined or 
patchy, and is predominantly located in the midwall myo-
cardial layer and does not correspond to a specific coronary 
artery territory (Fig. 2) [19, 32, 47, 48]. The presence and 
the extent of LGE have been associated with increased LV 
mass, worse LV ejection fraction, the presence of symp-
toms, markers of myocardial injury such NT-pro-brain 
natriuretic peptide and high-sensitivity cardiac troponins 
and ECG strain (Table  2) [19, 32, 45, 46, 48, 49]. How-
ever, LGE was not significantly associated with transaortic 
gradients or the aortic valve area, common indices of AS 
severity [19, 32, 48], suggesting that there is different indi-
vidual susceptibility to develop LV hypertrophy and myo-
cardial fibrosis, likely influenced by multiple factors such 
as advanced age, male sex, obesity and certain genetic vari-
ants [50].
In addition, LGE is an important prognostic marker 
in patients with AS [19, 32, 33]. In 143 patients 
with moderate and severe AS who were followed for 
2.0 ± 1.4 years, the presence of LGE was associated with 
an increase in all-cause and cardiac mortality (every 1% 
increase in LGE mass was associated with 5% increased 
risk of all-cause mortality; p = 0.005) [19]. When divid-
ing the population according to the pattern of LGE, 
patients with midwall fibrosis (N = 54) had higher mor-
tality than patients with infarct-type LGE (N = 40) (HR 
8.59; 95% CI 1.97–37.38; p = 0.004 and HR 6.46; 95% CI 
1.39–30.00; p = 0.017, respectively). Furthermore, in 154 
patients with severe AS undergoing surgical aortic valve 
replacement, the presence of LGE was an independent 
predictor of all-cause and cardiovascular mortality (HR 
for all-cause mortality: 2.8; 95% CI 1.3–6.9; p = 0.025) 
[32]. Importantly, after aortic valve replacement, LGE 
does not completely regress and has been associated with 
incomplete LV functional recovery, worse New York 
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Table 2  CMR studies to detect myocardial fibrosis in valvular heart disease
Study No. of patients Valve disease CMR technique Main findings
Bull et al. [40] 109 AS Native T1 mapping Native T1 values increased along 
with hemodynamic severity of AS 
and correlated with the degree of 
biopsy-quantified fibrosis (R = 0.65; 
p = 0.002; N = 23)
Lee et al. [41] 80 AS Native T1 mapping Native T1 values at 3T CMR were 
significantly longer in asympto-
matic patients with moderate to 
severe AS compared to normal 
controls
Flett et al. [8] 18 AS ECV ECV correlated strongly with col-
lagen volume fraction on histology 
 (R2 = 0.86; p < 0.001)
Dusenbery et al. [44] 35 AS ECV ECV was significantly higher in 
patients with congenital AS than in 
normal subjects
Flett et al. [43] 66 AS ECV Patients with severe AS had higher 
ECV than normal controls
Chin et al. [34] 166 AS iECV, LGE Increased iECV was associated with 
increased all-cause mortality com-
pared to patients with normal iECV 
(36 vs. 8 deaths/1000 patient-years, 
respectively)
Chin et al. [45] 122 AS ECV, LGE ECV and percent of midwall replace-
ment fibrosis (LGE) were associ-
ated with increased high-sensitivity 
cardiac troponin I levels
Shah et al. [46] 102 AS ECV, LGE LGE and ECV were associated with 
ECG strain in patients with mild to 
severe AS
Debl et al. [47] 22 AS LGE LGE was associated with severe LV 
hypertrophy
Rudolph et al. [48] 21 AS LGE LGE was associated with increased 
LV mass index and LV end-dias-
tolic volume index. LGE was not 
associated with the severity of AS
Dweck et al. [19] 143 AS LGE Midwall fibrosis on LGE CMR was 
associated with higher mortality 
than infarct-type LGE (HR 8.59; 
95% CI 1.97–37.38; p = 0.004 
and HR 6.46; 95% CI 1.39-30.00; 
p = 0.017, respectively)
Barone-Rochette et al. [32] 154 AS LGE LGE was an independent predictor of 
all-cause and cardiovascular mor-
tality in patients with severe AS 
undergoing surgical valve replace-
ment (HR for all-cause mortality: 
2.8; 95% CI 1.3–6.9; p = 0.025)
Weidemann et al. [49] 58 AS LGE The extent of LGE in patients with 
symptomatic severe AS undergo-
ing aortic valve surgery correlated 
with biopsy-quantified myocardial 
fibrosis and remained unchanged at 
9 months after surgery
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Table 2  (continued)
Study No. of patients Valve disease CMR technique Main findings
Azevedo et al. [33] 54 AS + AR LGE LGE correlated with the extent of 
fibrosis on histology (r = 0.69, 
p < 0.001) and demonstrated sig-
nificant inverse correlation with the 
LVEF improvement after surgery 
(r=-0.47, p = 0.02)
LGE was associated with worse long-
term survival (Chi square = 5.85; 
p = 0.02)
Singh et al. [51] 174 AS LGE Patients with asymptomatic moderate 
and severe AS who presented with 
valve related complications during 
follow-up showed comparable 
extent of LGE than patients who 
remained asymptomatic
Schneeweis et al. [54], Singh et al. 
[55]
30, 18 AS CMR tagging, feature tracking 
CMR
Reasonable agreement between both 
techniques, but feature tracking 
CMR yielded higher strain values 
than CMR tagging
Mahmod et al. [57] 39 AS CMR tagging Patients with AS had impaired LV 
strain compared to controls
Al Musa et al. [56] 42 AS CMR tagging, feature tracking 
CMR
Longitudinal strain rate was impaired 
in symptomatic vs. asymptomatic 
patients with severe AS and pre-
served LVEF (−83.4 ± 24.8%/s and 
− 106.3 ± 43.3%/s, respectively; 
P = 0.048)
Musa et al. [36] 98 AS CMR tagging Impaired mid-LV circumferential 
strain was associated with all-cause 
mortality after aortic valve replace-
ment (HR 1.03; 95% CI 1.01–1.05; 
p = 0.009)
Meyer et al. [58] 44 AS Feature tracking CMR Peak systolic LV strain of the api-
cal segments was significantly 
impaired in transapical versus 
transfemoral transcatheter aortic 
valve replacement
Sparrow et al. [62] 8 AR T1 mapping Post-contrast T1 values in abnor-
mally contracting segments were 
prolonged compared to controls 
(532 vs. 501 ms, respectively; 
p = 0.002)
de Meester de Ravenstein [63] 9 AR ECV ECV measured on 3T CMR was 
strongly correlated with the extent 
of interstitial fibrosis on histol-
ogy in patients with severe AR 
(r = 0.79, p = 0.011)
Pomerantz et al. [64] 14 AR Myocardial tagging Global longitudinal and circumfer-
ential strain were decreased 2 years 
after aortic valve replacement, 
despite an improvement in LVEF 
and LV size
Ungacta et al. [65] 8 AR Myocardial tagging Posterior wall circumferential strain 
was decreased 6 months after 
surgery
Edwards et al. [68] 35 MR ECV, native T1 mapping, LGE Patients with moderate to severe 
primary MR had higher ECV com-
pared to controls (0.32 ± 0.07 vs. 
0.25 ± 0.02, respectively; p < 0.01)
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Heart Association functional class and worse survival 
(Fig. 6) [32, 33, 49]. However, detection of LV myocar-
dial fibrosis in patients with asymptomatic moderate and 
severe AS seems insufficient to identify the patients who 
will present valve related complications. In the prog-
nostic importance of microvascular dysfunction in aor-
tic stenosis (PRIMID AS) study, including 174 patients 
with asymptomatic moderate to severe AS, the group of 
patients who presented with cardiovascular death, major 
adverse cardiovascular events and development of typi-
cal AS symptoms, necessitating referral for aortic valve 
replacement, showed comparable extent of LGE than 
patients who remained asymptomatic or free of valve 
related complications during follow-up [51].
Table 2  (continued)
Study No. of patients Valve disease CMR technique Main findings
Han et al. [69] 25 MR LGE LGE of the papillary muscles was 
present in 63% of patients with MV 
prolapse
Chaikriangkrai et al. [35] 48 MR LGE The presence of LV LGE in chronic 
severe MR was associated with 
worse clinical outcomes (HR 4.8; 
95% CI 1.1–20.7; p = 0.037)
Maniar et al. [70] 15 MR CMR tagging Patients with chronic moderate and 
severe MR and preserved LVEF 
had impaired septal LV strain val-
ues compared to normal controls
Mankad et al. [71] 7 MR CMR tagging Patients with severe MR and 
preserved LVEF had reduced 
circumferential strain compared 
to controls (12 ± 6 vs. 21 ± 6%, 
respectively; p ≤ 0.001)
Ahmed et al. [72], Schiros et al. 
[73], Ahmed et al. [74]
27
35
22
MR CMR tagging Global longitudinal and circum-
ferential strain parameters were 
decreased after MV repair
AS aortic stenosis, AR aortic regurgitation, CMR cardiovascular magnetic resonance, ECV extracellular volume, HR hazard ratio, ICU intensive 
care unit, iECV indexed extracellular volume, LGE late gadolinium enhancement, LV left ventricle, LVEF left ventricular ejection fraction, MR 
mitral regurgitation
Fig. 4  Native T1 mapping in aortic stenosis. A Color maps of T1 
values of mid-ventricular short-axis slices (top row) and correspond-
ing LGE images (bottom row) of normal controls and patients with 
moderate and severe AS. The left column shows a normal volunteer 
(T1 = 944  ms), the middle column a patient with moderate AS and 
moderate left ventricular hypertrophy (T1 = 951  ms) and the right 
column shows a patient with severe AS with severe left ventricular 
hypertrophy (T1 = 1020 ms). B Whisker-plots of myocardial T1 val-
ues of normal controls and of patients with moderate AS, asympto-
matic severe AS and symptomatic severe AS. The between-group 
comparisons with the corresponding p-values are also presented. AS 
aortic stenosis, LGE late gadolinium enhancement, ns non-signifi-
cant. Adapted with permission from Bull et al. [40] 
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Interstitial and replacement myocardial fibrosis lead 
to impaired LV myocardial deformation which can be 
detected with strain imaging. Myocardial tagging and fea-
ture tracking CMR demonstrated that global as well as 
regional LV strains were significantly correlated with LGE 
extent in patients with hypertrophic cardiomyopathy, who 
exhibit a similar pattern of midwall fibrosis to patients with 
AS [52, 53]: global and regional LV strain values impair as 
LGE increases. Head-to-head comparisons between tagged 
and feature tracking CMR in moderate to severe AS have 
shown reasonable agreement for LV strain measurement, 
albeit feature tracking provided systematically higher val-
ues than CMR tagging [54, 55]. The correlation between 
CMR LV circumferential and longitudinal strain and strain 
rate and symptomatic status of patients with severe AS and 
preserved LV ejection fraction was demonstrated by Al 
Musa et al. [56]. LV longitudinal strain rate was the most 
sensitive parameter to discriminate between asymptomatic 
versus symptomatic patients (−106.3 ± 43.3%/s in patients 
with “no/mild” symptoms vs. −83.4 ± 24.8%/s in moder-
ate and severely symptomatic patients; P = 0.048). The 
association between LV myocardial strain and outcomes 
after surgical or transcatheter treatment was demonstrated 
in two studies [36, 57]. Mahmod and coworkers showed 
that global LV circumferential, but not longitudinal strain 
measured on CMR significantly improved at 8 months after 
aortic valve replacement [57]. Similarly, LV circumferen-
tial strain by CMR tagging was significantly associated 
with all-cause mortality in 98 severe AS patients under-
going surgical and transcatheter aortic valve replacement 
(HR per each 1% deterioration of circumferential strain: 
1.03; 95% CI 1.01–1.05; p = 0.009) [36]. Furthermore, the 
effect of procedural access (transfemoral vs. transapical) 
on LV mechanics was studied with CMR feature track-
ing in 44 patients undergoing transcatheter aortic valve 
replacement [58]. The transapical approach was associ-
ated with impaired peak systolic longitudinal strain of the 
apical segments as compared to the transfemoral approach 
(−8.9 ± 5.3 vs. −16.9 ± 4.3%, respectively; p < 0.001), 
while there were no differences in LV ejection fraction and 
peak systolic longitudinal strain of the basal and midven-
tricular segments between both approaches (Fig. 7).
Aortic regurgitation
In aortic regurgitation (AR), pressure and volume over-
load induce growth of cardiomyocytes with addition of 
new sarcomeres in series and interstitial fibrosis, charac-
terized by increased fibronectin and non-collagen com-
ponents [59]. Several clinical studies have histologically 
proven pronounced myocardial fibrosis in severe AR at 
the time of valve surgery [37, 60, 61]. A few studies have 
Fig. 5  Prognostic implications of interstitial and replacement fibro-
sis in aortic stenosis. A Patients with mild to severe aortic stenosis 
were categorized into three groups based upon cardiovascular mag-
netic resonance assessments of myocardial fibrosis: normal myo-
cardium [indexed extracellular volume (iECV) < 22.5  ml/m2, no 
late gadolinium enhancement (LGE)], diffuse myocardial fibrosis 
(iECV ≥ 22.5  ml/m2, no LGE) and replacement fibrosis (presence 
of midwall LGE). There was a stepwise increase in: B severity of 
valve narrowing; C degree of left ventricular (LV) hypertrophy; D 
myocardial injury, assessed by high-sensitivity troponin I concentra-
tion (hsTni); E LV diastolic dysfunction; and F all-cause-mortality 
with increased diffuse myocardial fibrosis and replacement fibrosis. 
Adapted with permission from Chin et al. [34] 
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also evaluated myocardial fibrosis with CMR [33, 62, 
63]. Sparrow et al. compared myocardial T1 values meas-
ured with a modified Look-Locker technique before and 
after gadolinium contrast in eight patients with severe AR 
and 15 normal controls [62]. Patients with AR had signif-
icantly prolonged post-contrast T1 values in abnormally 
contracting segments compared to the controls (532 vs. 
501  ms, respectively; p = 0.002), suggesting increased 
interstitial fibrosis. Furthermore, in nine patients with 
severe AR who underwent surgical aortic valve replace-
ment, ECV measured on 3T CMR was strongly corre-
lated with the extent of interstitial fibrosis on histology 
(r = 0.79, p = 0.011) [63]. Replacement fibrosis has been 
also described in 26 patients with severe AR by Azevedo 
et  al. [33]. The authors reported a 69% prevalence of 
LGE, mostly following a multifocal pattern. The corre-
lation between myocardial replacement fibrosis assessed 
with LGE and histopathology was good (r = 0.70, 
p < 0.001). Moreover, in a combined cohort of 26 patients 
with severe AR and 28 patients with severe AS, the 
amount of myocardial fibrosis was inversely correlated 
with LV functional improvement (r = −0.47; p = 0.02) and 
was associated with worse long-term survival after aortic 
valve replacement surgery (Chi square = 5.85; p = 0.02) 
(Fig.  6) [33]. Furthermore, in 14 patients with chronic 
severe AR, myocardial CMR tagging showed an impair-
ment in global longitudinal and circumferential strain at 
2 years after aortic valve replacement (p < 0.03 for both), 
despite an improvement in LV ejection fraction and a 
decrease in LV size (Fig. 8) [64]. Similarly, Ungacta et al. 
showed a decrease in posterior wall circumferential strain 
in patients with AR 6  months after valve replacement 
[65]. These findings suggest that the presence of LV myo-
cardial fibrosis in patients with AR is a marker of adverse 
remodeling that may lead to further deterioration in LV 
strain and poor prognosis after aortic valve surgery.
Fig. 6  Prognostic implications of late gadolinium enhancement 
(LGE) cardiovascular magnetic resonance (CMR) in patients with 
severe aortic stenosis and aortic regurgitation after aortic valve 
replacement surgery. Linear regression graphs illustrate the inverse 
relationship between the degree of left ventricular ejection fraction 
improvement and the amount of myocardial fibrosis by histopathol-
ogy (A) and by LGE CMR (B). The Kaplan–Meier graphs demon-
strate significantly worse survival after aortic valve replacement in 
patients with larger myocardial fibrosis assessed by histopathology 
(C) or LGE (D). Reproduced with permission from Azevedo et  al. 
[33] ce-MRI contrast-enhanced magnetic resonance imaging, EF 
ejection fraction, MF myocardial fibrosis
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Mitral regurgitation
Mitral regurgitation (MR) is a heterogeneous disease, 
broadly classified as organic (primary) or functional (sec-
ondary) based on the underlying mechanism. Organic MR 
is due to intrinsic valvular disease whereas functional MR 
is caused by regional and/or global LV remodeling without 
structural abnormalities of the mitral valve [66]. Degenera-
tive mitral valve disease (myxomatous disease and fibroe-
lastic deficiency) is the most frequent etiology of primary 
MR in developed countries. The indication for mitral valve 
repair/replacement is determined by the presence of symp-
toms or LV function deterioration and LV remodeling [1, 
3]. However, LV remodeling and myocardial fibrosis may 
occur before the development of symptoms. Chronic LV 
volume overload associated with MR leads to myocardial 
hypertrophy and increased interstitial fibrosis [67]. In 35 
asymptomatic patients with moderate to severe primary 
MR, Edwards et al. demonstrated higher ECV on CMR as 
compared to controls (0.32 ± 0.07 vs. 0.25 ± 0.02, p < 0.01) 
(Fig.  9) [68]. Furthermore, 31% of patients with MR 
exhibited a non-infarct LGE pattern on CMR. Patients who 
had non-infarct type LGE presented with higher ECV val-
ues compared to MR patients without LGE (0.35 ± 0.02 vs. 
0.27 ± 0.03, p < 0.01). The ECV values correlated with LV 
end-systolic volume, measures of systolic and diastolic LV 
dysfunction as well as with peak oxygen consumption on 
treadmill testing. The distribution of LGE in patients with 
MR varies significantly. Han et al. demonstrated the pres-
ence of LGE of the papillary muscles in 63% of patients 
with MV prolapse [69] whereas Chaikriangkrai et  al. 
observed LV replacement fibrosis in 40% of patients with 
chronic severe MR [35]. The presence of LV LGE was 
associated with worse clinical outcomes in terms of inten-
sive care unit readmission, incidence of permanent pace-
maker implantation and rehospitalization (HR 4.775; 95% 
CI 1.100–20.729; p = 0.037) [35].
These structural changes of the LV myocardium may 
be associated with subtle functional abnormalities. In 15 
patients with chronic moderate and severe MR and pre-
served LV ejection fraction who underwent CMR with 
tissue tagging, Maniar et  al. demonstrated preserved 
Fig. 7  The impact of tran-
scatheter aortic valve implan-
tation on the left ventricular 
(LV) mechanics, assessed 
with feature tracking cardio-
vascular magnetic resonance 
(CMR). A Systolic CMR cine 
frames derived from four- (top 
row), three- (middle row), and 
two-chamber (bottom row) LV 
views of a patient before and 
after transfemoral (TF) access 
(left two columns) as well as 
from a patient before and after 
transapical (TA) access (right 
two columns). The green arrows 
represent velocity vectors illus-
trating systolic inward motion. 
The TA transcatheter aortic 
valve implantation (TAVI) 
patient shows reduced systolic 
deformation of the apical LV 
segments 3 months after the 
procedure. B Average peak 
systolic radial strain values of 
49 analyzed segments obtained 
from all TF-TAVI patients (blue 
line) and all TA-TAVI patients 
(red line). The apical segments 
are displayed in the middle, 
while the basal segments are 
displayed on the left and on the 
right side of the graph. There is 
a reduction in peak radial strain 
of the apical segments after TA-
TAVI. Adapted with permission 
from Meyer et al. [58]
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Fig. 8  CMR tagging in patients with chronic severe aortic regurgita-
tion. Left ventricular (LV) long-axis (top row) and short-axis (bottom 
row) cardiovascular magnetic resonance (CMR) tagging images at 
end-diastole (A) and at end-systole (B). A tagging pattern in the form 
of parallel lines was used for the long-axis cines and a grid pattern for 
the short-axis cines. Dedicated software was employed for the myo-
cardial deformation analysis. C At an average of 28 ± 11 months after 
aortic valve replacement global and regional LV longitudinal and cir-
cumferential strain decreased (p < 0.05 for both global strain values) 
despite an improvement in LV ejection fraction and a decrease in LV 
size, which might imply an ongoing myocardial fibrosis after valve 
surgery. Adapted with permission from Pomerantz et al. [64]. AI aor-
tic insufficiency, Ant anterior, Lat lateral, Post posterior, preop preop-
erative, postop postoperative, Sept septal
Fig. 9  Cardiovascular magnetic resonance (CMR) myocardial fibro-
sis assessment in primary degenerative mitral regurgitation (MR). A 
Late gadolinium enhanced CMR images (top) and native T1 maps 
(bottom) in patients with MR. The arrows indicate the presence of 
midwall replacement fibrosis in the inferolateral wall. The native T1 
values were increased in corresponding areas (Hash 1045  ms and 
Asterisk 1102  ms). B Left ventricular fibrosis demonstrated on his-
tology: replacement fibrosis can be well-delineated (upper plot) or 
patchy (lower plot). C Individual patient data presented in the scatter 
plot demonstrate a wide overlap of the extracellular volume (ECV) 
values in patients with MR and controls. However, the mean and the 
standard error of the mean (error bars) were significantly larger in 
patients with MR as compared to the controls. Adapted with permis-
sion from Edwards et al. [68] 
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global longitudinal and circumferential strain but abnor-
mal regional strain values: the septal LV segments exhib-
ited impaired strain whereas the lateral segments showed 
compensatory hyper-contractility [70]. Similarly, Mankad 
et  al. showed with CMR tagging abnormal regional 
strain patterns in patients with severe MR and preserved 
LV ejection fraction: while radial strain was increased 
(19 ± 9 vs. 16 ± 6%, p = 0.003), circumferential strain 
was reduced (12 ± 6 vs. 21 ± 6%, p ≤ 0.001) as compared 
to healthy controls [71]. Several authors have demon-
strated a decrease in global longitudinal and circumfer-
ential strain parameters on CMR tagging in patients with 
severe degenerative MR after mitral valve repair, which 
might imply an ongoing myocardial fibrosis after surgery 
[72–74].
Future perspectives
Tissue characterization and strain imaging with CMR have 
provided new insights into the pathophysiology of VHD. 
Current guidelines recommend valve surgery in severe 
symptomatic VHD or when LV function decreases [1, 3]. 
However, early detection of LV structural and functional 
changes may help to identify patients who may benefit 
from early surgery. It is conceivable that early relief of the 
pressure or volume overload would result in less damage 
to the LV and better outcome at follow-up. However, there 
are currently no prospective data to evaluate whether early 
surgical valve treatment results in better prognosis in VHD. 
It may be challenging as well to define the cut-off values of 
ECV, T1 times, LGE and LV myocardial strains for thera-
peutic intervention. Standardization in data acquisition and 
analysis are important issues to be resolved.
The early valve replacement guided by biomarkers of 
left ventricular decompensation in asymptomatic patients 
with advanced aortic stenosis (EVOLVED) is the first 
multicenter randomized controlled clinical trial that 
will investigate whether the early valve intervention in 
patients with asymptomatic severe AS and midwall fibro-
sis on CMR improves patients’ clinical outcomes com-
pared to the standard care (NCT03094143). The results 
of this study may have an impact on future guidelines and 
recommendations on treatment of VHD.
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